161 related articles for article (PubMed ID: 9254630)
1. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria.
Wiese A; Brandenburg K; Carroll SF; Rietschel ET; Seydel U
Biochemistry; 1997 Aug; 36(33):10311-9. PubMed ID: 9254630
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates.
Wiese A; Brandenburg K; Lindner B; Schromm AB; Carroll SF; Rietschel ET; Seydel U
Biochemistry; 1997 Aug; 36(33):10301-10. PubMed ID: 9254629
[TBL] [Abstract][Full Text] [Related]
3. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
4. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
Weiss J; Muello K; Victor M; Elsbach P
J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924
[TBL] [Abstract][Full Text] [Related]
5. Impact of the glycostructure of amphiphilic membrane components on the function of the outer membrane of Gram-negative bacteria as a matrix for incorporated channels and a target for antimicrobial peptides or proteins.
Gutsmann T; Seydel U
Eur J Cell Biol; 2010 Jan; 89(1):11-23. PubMed ID: 19939497
[TBL] [Abstract][Full Text] [Related]
6. Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes.
Wiese A; Gutsmann T; Seydel U
J Endotoxin Res; 2003; 9(2):67-84. PubMed ID: 12803879
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
8. rBPI21 interacts with negative membranes endothermically promoting the formation of rigid multilamellar structures.
Domingues MM; Bianconi ML; Barbosa LR; Santiago PS; Tabak M; Castanho MA; Itri R; Santos NC
Biochim Biophys Acta; 2013 Nov; 1828(11):2419-27. PubMed ID: 23792068
[TBL] [Abstract][Full Text] [Related]
9. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
[TBL] [Abstract][Full Text] [Related]
10. Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides.
Gutsmann T; Hagge SO; David A; Roes S; Böhling A; Hammer MU; Seydel U
J Endotoxin Res; 2005; 11(3):167-73. PubMed ID: 15949145
[TBL] [Abstract][Full Text] [Related]
11. Recombinant bactericidal/permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis.
Zhang LT; Yao YM; Lu JQ; Yan XJ; Yu Y; Sheng ZY
Shock; 2008 Feb; 29(2):278-84. PubMed ID: 17693935
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli.
Wu M; Maier E; Benz R; Hancock RE
Biochemistry; 1999 Jun; 38(22):7235-42. PubMed ID: 10353835
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of bactericidal/permeability-increasing protein in experimental otitis media with effusion in rats: a new therapy for mucosal infections.
Nell MJ; Grote JJ
J Lab Clin Med; 2001 Apr; 137(4):303-9. PubMed ID: 11283526
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies.
Domingues MM; Santos NC; Castanho MA
Curr Protein Pept Sci; 2012 Nov; 13(7):611-9. PubMed ID: 23116442
[TBL] [Abstract][Full Text] [Related]
15. Interaction between lipopolysaccharide (LPS), LPS-binding protein (LBP), and planar membranes.
Gutsmann T; Haberer N; Carroll SF; Seydel U; Wiese A
Biol Chem; 2001 Mar; 382(3):425-34. PubMed ID: 11347890
[TBL] [Abstract][Full Text] [Related]
16. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
[TBL] [Abstract][Full Text] [Related]
17. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis.
Hammer MU; Brauser A; Olak C; Brezesinski G; Goldmann T; Gutsmann T; Andrä J
Biochem J; 2010 Apr; 427(3):477-88. PubMed ID: 20187872
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria.
Domingues MM; Silva PM; Franquelim HG; Carvalho FA; Castanho MA; Santos NC
Nanomedicine; 2014 Apr; 10(3):543-51. PubMed ID: 24262996
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI).
Azuma M; Matsuo A; Fujimoto Y; Fukase K; Hazeki K; Hazeki O; Matsumoto M; Seya T
Biochem Biophys Res Commun; 2007 Mar; 354(2):574-8. PubMed ID: 17239348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
